ENDOTAK ENDURANCE
Report
- Report Number
- 2124215-2012-16202
- Event Type
- Injury
- Date Received
- January 11, 2013
- Date of Event
- December 3, 2012
- Report Date
- February 13, 2013
- Manufacturer
- CPI - DEL CARIBE
- Product Code
- NVY
- PMA / PMN Number
- P910073
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE
Narratives
ADDITIONAL INFORMATION HAS BEEN RECEIVED THAT THE THRESHOLDS HAVE RISEN AND INTERMITTANT CAPTURE HAS BEEN NOTED. THE PATIENT WILL BE HAVING A MASECTOMY IN JANUARY AND THE LEAD WILL BE REVISED SOMETIME AFTER THAT PROCEDURE.
ADDITIONAL INFORMATION WAS RECEIVED THAT THIS LEAD HAS BEEN SURGICALLY ABANDONED. A NEW LEAD WAS SUCCESSFULLY IMPLANTED WITH NO ISSUES. THERE WERE NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED.
ALL AVAILABLE INFORMATION INDICATES THE DEVICE REMAINS IN SERVICE. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.
--
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS RIGHT VENTRICULAR (RV) LEAD EXHIBITED HIGH OUT OF RANGE SHOCK IMPEDANCE MEASUREMENTS. THE LEAD HAD BEEN INTERMITTENTLY GIVING HIGH IMPEDANCE. THERE IS NO EVIDENCE OF NOISE AND ALL OTHER MEASUREMENTS ARE GOOD. BOSTON SCIENTIFIC TECHNICAL SERVICES (TS) RECOMMENDED MONITORING THE LEAD OR BRINGING THE PATIENT IN FOR ISOMETRICS. THERE WERE NO ADVERSE PATIENT EFFECTS REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 18777 | ENDOTAK ENDURANCE | IMPLANTABLE LEAD | NVY | CPI - DEL CARIBE | 0144 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 72 YR | Hospitalization| L| R | 1851| E110| 0144| T165| 5068 |